Eyenovia Inc. announced the appointment of John Gandolfo as chief financial officer (CFO) effective December 18, 2017. Mr. Gandolfo has more than 30 years of experience in executive and senior management positions with high growth public and private companies, primarily in the medical devices and life sciences sectors. Prior to joining Eyenovia, Mr. Gandolfo spent more than seven years at Xtant Medical Holdings, Inc., where he served as CFO. He has also served as the CFO at Progenitor Cell Therapy LLC, Power Medical Interventions, Inc., and Bioject, Inc.